» Articles » PMID: 32069337

Validation of a Hierarchical Algorithm to Define Chronic Liver Disease and Cirrhosis Etiology in Administrative Healthcare Data

Overview
Journal PLoS One
Date 2020 Feb 19
PMID 32069337
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: Chronic liver disease (CLD) and cirrhosis are leading causes of death globally with the burden of disease rising significantly over the past several decades. Defining the etiology of liver disease is important for understanding liver disease epidemiology, healthcare planning, and outcomes. The aim of this study was to validate a hierarchical algorithm for CLD and cirrhosis etiology in administrative healthcare data.

Methods: Consecutive patients with CLD or cirrhosis attending an outpatient hepatology clinic in Ontario, Canada from 05/01/2013-08/31/2013 underwent detailed chart abstraction. Gold standard liver disease etiology was determined by an attending hepatologist as hepatitis C (HCV), hepatitis B (HBV), alcohol-related, non-alcoholic fatty liver disease (NAFLD)/cryptogenic, autoimmune or hemochromatosis. Individual data was linked to routinely collected administrative healthcare data at ICES. Diagnostic accuracy of a hierarchical algorithm incorporating both laboratory and administrative codes to define etiology was evaluated by calculating sensitivity, specificity, positive (PPV) and negative predictive values (NPV), and kappa's agreement.

Results: 442 individuals underwent chart abstraction (median age 53 years, 53% cirrhosis, 45% HCV, 26% NAFLD, 10% alcohol-related). In patients with cirrhosis, the algorithm had adequate sensitivity/PPV (>75%) and excellent specificity/NPV (>90%) for all etiologies. In those without cirrhosis, the algorithm was excellent for all etiologies except for hemochromatosis and autoimmune diseases.

Conclusions: A hierarchical algorithm incorporating laboratory and administrative coding can accurately define cirrhosis etiology in routinely collected healthcare data. These results should facilitate health services research in this growing patient population.

Citing Articles

Primary sclerosing cholangitis-inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence.

Leung K, Li W, Hansen B, Gulamhusein A, Lapointe-Shaw L, Shaheen A JHEP Rep. 2025; 7(3):101272.

PMID: 40041117 PMC: 11876923. DOI: 10.1016/j.jhepr.2024.101272.


Comparing the Risk of Poor Outcomes Among Hepatitis C-Infected, Cured, and Never-Infected Controls.

Saxena V, Wu W, Balasubramanian S, Mukhtar N, Seo S, Ready J Gastro Hep Adv. 2024; 3(6):871-879.

PMID: 39280914 PMC: 11401574. DOI: 10.1016/j.gastha.2024.04.015.


Validating new coding algorithms to improve identification of alcohol-associated and nonalcohol-associated cirrhosis hospitalizations in administrative databases.

Swain L, Godley J, Brahmania M, Abraldes J, Tang K, Flemming J Hepatol Commun. 2024; 8(7).

PMID: 38896072 PMC: 11186834. DOI: 10.1097/HC9.0000000000000469.


Colorectal Cancer in Individuals with Cirrhosis: A Population-Based Study Assessing Practice Patterns, Outcomes, and Predictors of Survival.

Patel S, Brennan K, Zhang L, Djerboua M, Nanji S, Merchant S Curr Oncol. 2023; 30(11):9530-9541.

PMID: 37999110 PMC: 10670829. DOI: 10.3390/curroncol30110690.


Associations between modest reductions in kidney function and adverse outcomes in young adults: retrospective, population based cohort study.

Hussain J, Grubic N, Akbari A, Canney M, Elliott M, Ravani P BMJ. 2023; 381:e075062.

PMID: 37353230 PMC: 10286512. DOI: 10.1136/bmj-2023-075062.


References
1.
Myers R, Shaheen A, Fong A, Wan A, Swain M, Hilsden R . Validation of coding algorithms for the identification of patients with primary biliary cirrhosis using administrative data. Can J Gastroenterol. 2010; 24(3):175-82. PMC: 2852223. DOI: 10.1155/2010/237860. View

2.
Caldwell S, Oelsner D, Iezzoni J, Hespenheide E, Battle E, Driscoll C . Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999; 29(3):664-9. DOI: 10.1002/hep.510290347. View

3.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

4.
Beste L, Leipertz S, Green P, Dominitz J, Ross D, Ioannou G . Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology. 2015; 149(6):1471-1482.e5. DOI: 10.1053/j.gastro.2015.07.056. View

5.
Hwang S, Agha M, Creatore M, Glazier R . Age- and sex-specific income gradients in alcohol-related hospitalization rates in an urban area. Ann Epidemiol. 2004; 15(1):56-63. DOI: 10.1016/j.annepidem.2004.04.003. View